Updated 08:05 GMT, 20 Nov 2026 SPX 7,175.83 -2.02% NDX 26,517.05 -2.21% VIX 28.44 +15.80% GOLD 3,574.90 -3.00% CL 82.63 -0.70% BTC 61,735.58 -0.27%
NAS100 26,517 −2.21% S&P 7,176 −2.02% GOLD $3,575 −3.00% BTC $61,736 −0.27% VIX 28.44 +15.80% latest tape · as of 08:05 UTC
The Screen · Consumer Cyclical · Home Improvement Retail

Lowe's

LOW · a US exchange · USD · Market cap $130.1B · 167,000 employees

Lowe's Companies, Inc., together with its subsidiaries, operates as a home improvement retailer in the United States and Canada.

FAIL · Does not pass the screen
219.14 USD

Price as of 19 Nov 2026Daily close, not a live quote

Screened 2026-11-19 · the tape above runs as of 08:05 UTC · two dates, stated on purpose · verdict and workings shown in full · never trimmed

Key facts today

  • Price219.14 USD at the 19 Nov 2026 close
  • Our value readFair vs our fair value, as of 19 Nov 2026
  • Our regime readMarkup, as of 15 Nov 2026
  • Ethical screenDoes not pass
  • OptionsOpen interest leans heavily to calls (put/call 0.68)
  • Last reviewed19 Nov 2026 (1 day ago)
  • Release timesRelease and earnings times on your chart: Event Guard Mentor

A summary of the dated readings below, not a live quote and not advice.

PRICE · ONE YEAR

Our fair-value range: $171.90 to $255.52, base estimate $222.19 (screen dated 2026-11-19).

Current read
Markup ?
Fair · screened 2026-11-19
  • Trend Markup
  • Insiders no filings inside 60 days, left as found
  • Positioning political selling, disclosed 2026-10-22
  • Options put/call open interest 0.68, read 2026-11-19
  • Ethical does not pass the values gate
Price219.14 USD
Fair value222.19
Ethical score10.0/100
Value readFairas of 19 Nov 2026
Our investment reviews on this name
2026-10-18Read Markup195.72+12.0% to today ✓Distribution gives way to Markup first Markup read since August
2026-10-11Read Distribution189.28+15.8% to today Markdown gives way to Distribution after a 6% slide in 3 weeks
2026-09-18Read Markdown200.80+9.1% to today Markup gives way to Markdown after a 9% slide in 5 weeks
2026-08-12Read Markup219.94-0.4% to today Distribution gives way to Markup while volume is distributing

Our analytic regime reads on this name, dated and marked against the screened price. Small sample per name, and separate from the daily-framework accuracy on the Track Record page.

The full research record, in depth, below
The Label · The Season, Not the Day

This name holds its markup label.

Lowe's holds its Markup at $219.14. Consolidating, no directional conviction, held for 19 days.

As held on the ledger · 2026-11-19
PhaseMarkup
Quantitative stateConsolidating, no directional conviction, held for 19 days
Price at the screen$219.14
Valuation19.60 trailing · 17.91 forward price to earnings
Values screenFAIL · score 10.0
Beta0.81
The Workings

Five Screens: LOW's Results

FAIL. Debt ratio

TestFigureLimitStatus
Business activity Permissible Permissible core business Pass
Debt load 82.52% Below 33% Fail
Interest-bearing cash 0.00% Below 33% Pass
Receivables 3.83% Below 49% Pass
Revenue purity 0.14% Below 5% Pass

Definitions, sources and threshold rules: ticker values-screen methodology.

The Ethical Read

Why It Falls Short, in Plain English

Lowe's's business is in a permissible area, but its interest-bearing debt is about 83% of the company, well over the ~33% line, so it does not pass on the financial screens.

Read as at 2026-11-19. It updates when the underlying figures move, and past reads are kept below.

Follow this verdict

Get an email when LOW's ethical verdict changes

Today LOW does not pass the screen. If new figures move it to a pass, we send you one short email with the before and after. Verdicts change rarely, so you may not hear from us for a long time.

Free, no account needed. Every email has a link to stop.

What the Numbers Say It Is Worth

The Fair Value Range

Our analysis reads Fair vs our fair value, as of 19 Nov 2026: it trades at roughly a 1% discount to our $222.19 fair value, 8.30% revenue growth.

Model construction and limits: fair-value methodology.

171.90Conservative222.19Base case255.52Growth case 219.14Price

Fair value range in USD, drawn from the 2026-11-19 screen. The gold marker is the market price at the same screen. A 1.4% discount to the base estimate.

The Street's Range
191.00Street low 255.00Street average 300.00Street high 219.14Price

Third-party analyst targets: 33 covering, consensus Buy. The average target sits +16% from the screen price.

Reading the gap · Our more conservative model reads it as roughly fairly valued here, while the Street is more bullish: a quality-at-a-fair-price name rather than a deep-value one.

Price History & Projections

Where our models see it going: fair-value estimate $222.19, with a range of $171.90 to $255.52, dated to the 2026-11-19 screen.

How our estimate and third-party targets differ.

The Business, in Plain Words
The fundamentals · plain-English read
Forward P/E17.9xexpensive even after accounting for its growth
Trailing P/E19.6xreasonably valued
EPS, trailing11.83
EPS, forward12.95
Revenue growth+8.3%steady growth
Profit margin7.3%thin but positive margins
FCF yield3.55%
Dividend yield2.27%
Current ratio1.11adequate liquidity, worth monitoring
Beta0.81steadier than the market
Short interest, float0.02%
52-week range178.45 - 293.06
Market cap$130.1B
Employees167,000

Metric definitions and interpretation rules: ticker-page methodology.

The Dated Journal · Newest First, Never Edited

Every Entry, As Written

2026-11-18 Markup $220.46 -3.2% Entry 26

The analysis reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 3.2% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading overbought. Over the past year the shares are down 2%. Our forward projection puts the odds of a 10% gain over the next month near 13%. The street (33 analysts) rates it buy, with a mean price target of $263. It reported earnings in this window, a natural checkpoint for the thesis.

2026-11-17 Markup $227.73 +0.0% Entry 25

The analysis reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading overbought. Over the past year the shares are down 2%. Our forward projection puts the odds of a 10% gain over the next month near 13%. The street (33 analysts) rates it buy, with a mean price target of $263. It reported earnings in this window, a natural checkpoint for the thesis.

2026-11-16 Markup $227.73 +0.0% Entry 24

The analysis reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading overbought. Over the past year the shares are down 2%. Our forward projection puts the odds of a 10% gain over the next month near 13%. The street (33 analysts) rates it buy, with a mean price target of $263. It reported earnings in this window, a natural checkpoint for the thesis.

2026-11-15 Markup $227.73 +0.0% Entry 23

The analysis reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading overbought. Over the past year the shares are down 2%. Our forward projection puts the odds of a 10% gain over the next month near 13%. The street (33 analysts) rates it buy, with a mean price target of $263. It reported earnings in this window, a natural checkpoint for the thesis.

2026-11-14 Markup $227.73 +0.1% Entry 22

The analysis reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved up 0.1% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading overbought. Over the past year the shares are down 2%. Our forward projection puts the odds of a 10% gain over the next month near 13%. The street (33 analysts) rates it buy, with a mean price target of $263. It reported earnings in this window, a natural checkpoint for the thesis.

2026-11-13 Markup $227.46 -1.8% Entry 21

The analysis reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 1.8% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading overbought. Over the past year the shares are down 2%. Our forward projection puts the odds of a 10% gain over the next month near 13%. The street (33 analysts) rates it buy, with a mean price target of $263. It reported earnings in this window, a natural checkpoint for the thesis.

2026-11-12 Markup $231.60 -0.1% Entry 20

The analysis reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 0.1% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading overbought. Over the past year the shares are down 2%. Our forward projection puts the odds of a 10% gain over the next month near 13%. The street (33 analysts) rates it buy, with a mean price target of $263. It reported earnings in this window, a natural checkpoint for the thesis.

2026-11-11 Markup $231.87 +3.3% Entry 19

The analysis reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved up 3.3% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading overbought. Over the past year the shares are down 2%. Our forward projection puts the odds of a 10% gain over the next month near 13%. The street (33 analysts) rates it buy, with a mean price target of $263. It reported earnings in this window, a natural checkpoint for the thesis.

2026-11-08 Markup $224.55 +7.4% Entry 18

The analysis reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved up 7.4% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading bullish. Over the past year the shares are down 2%. Our forward projection puts the odds of a 10% gain over the next month near 13%. The street (33 analysts) rates it buy, with a mean price target of $263.

2026-11-01 Markup $209.07 +6.8% Entry 17

The analysis reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved up 6.8% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading bullish. Over the past year the shares are down 2%. Our forward projection puts the odds of a 10% gain over the next month near 13%. The street (33 analysts) rates it buy, with a mean price target of $263.

Each entry above was written on its date, before the outcome. A journal you can prune is not a journal.

Latest News · What the Market Is Reading on LOW

Headlines from third-party outlets, linked for reference: not our reporting, not advice.

Related Securities · Others in LOW's Space

Screened names in the same industry · explore each on its own page.

The Insider Ledger · Form 4 Filings, As Filed
Most recent filings · LOW
DateInsiderTitleTypeSharesValue
2026-04-01 PRYOR JULIETTE WILLIAMS Officer 5,141 ·
2026-04-01 BOLTZ WILLIAM P. Officer 9,535 ·
2026-04-01 GODBOLE SEEMANTINI P Chief Technology Officer 9,145 ·
2026-04-01 GRIGGS DAN CLAYTON JR. Officer 1,526 ·
2026-04-01 SINK BRANDON J. Chief Financial Officer 8,349 ·
2026-04-01 DUPRE JANICE M. Officer 5,185 ·
2026-04-01 VANCE QUONTA D Officer 4,793 ·
2026-04-01 VAGELL MARGRETHE R Officer 4,653 ·
2026-04-01 MCFARLAND JOSEPH MICHAEL III Officer 9,535 ·
2026-04-01 ELLISON MARVIN R Chief Executive Officer 37,292 ·

Public filings, recorded as found. The full tape lives at Insider Intelligence.

The Political Ledger · Congressional Disclosures
Disclosures naming LOW
DatePoliticianPartyTypeAmount
2026-10-22 Pete Sessions Republican sell 15K–50K
2026-10-22 Pete Sessions Republican sell 15K–50K
2026-10-22 Pete Sessions Republican sell 15K–50K
2026-10-13 Ro Khanna Democrat buy 15K–50K
2026-10-07 Ro Khanna Democrat buy 15K–50K
What Holding Actually Paid · Price Plus Dividends
If $1,000 had been placed · historical, not a promise
PeriodPrice thenPrice returnDivs per share$1,000 becameTotal return
1 month $194.69 +14.4% $1.25 $1,151 +15.1%
2 months $191.28 +16.5% $1.25 $1,171 +17.1%
3 months $215.97 +3.2% $1.25 $1,037 +3.7%
6 months $212.36 +4.9% $2.50 $1,061 +6.1%
1 year $214.85 +3.7% $4.90 $1,060 +6.0%
2 years $260.70 -14.6% $9.60 $891 -10.9%
3 years $191.75 +16.2% $14.10 $1,235 +23.5%
5 years $225.88 -1.4% $22.10 $1,084 +8.4%

Historical returns from market close data. Past performance does not guarantee future results.

The Ledger's Promise

This entry now belongs to the ledger. Whatever LOW does next, these words stay.

Lowe's · LOW · Markup · $219.14
Recorded 2026-11-19 · before the outcome · scored mechanically

Membership

Thirteen thousand names carry this page. One desk keeps them honest.

Membership opens the full screen archive, the composites built from it, and the daily coverage that prices what the screen approves.

Join the desk

Screening is research, not a fatwa and not financial advice. Figures are drawn from public accounts at the screen date shown. Always manage your risk.

Get our weekly market brief free.